Related references
Note: Only part of the references are listed.Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK
Refaat A. Eid et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes
Nian Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
Ellagic acid protects against diabetic nephropathy in rats by regulating the transcription and activity of Nrf2
Jozaa Z. ALTamimi et al.
JOURNAL OF FUNCTIONAL FOODS (2021)
AMPK against NASH
Paulina Strzyz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Unripe Rubus coreanus Miquel Extract Containing Ellagic Acid Regulates AMPK, SREBP-2, HMGCR, and INSIG-1 Signaling and Cholesterol Metabolism In Vitro and In Vivo
Ki Hoon Lee et al.
NUTRIENTS (2020)
Catalpol Attenuates Hepatic Steatosis by Regulating Lipid Metabolism via AMP-Activated Protein Kinase Activation
Xiang Tian et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid
Guendalina Zuccari et al.
APPLIED SCIENCES-BASEL (2020)
Recent Advances in the Production and Applications of Ellagic Acid and Its Derivatives. A Review
Dmitry D. Evtyugin et al.
MOLECULES (2020)
Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress
Jasmina Djedjibegovic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Regulation of hepatic oxidative stress by voltage-gated proton channels (Hv1/VSOP) in Kupffer cells and its potential relationship with glucose metabolism
Takafumi Kawai et al.
FASEB JOURNAL (2020)
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Marieke de Vries et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Ellagic acid prevents kidney injury and oxidative damage via regulation of Nrf-2/NF-κB signaling in carbon tetrachloride induced rats
Abdullah Aslan et al.
MOLECULAR BIOLOGY REPORTS (2020)
Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha
Liying Ren et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
AMPK activation attenuates inflammatory pain through inhibiting NF-B activation and IL-1 expression
Hong-Chun Xiang et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Ellagic acid protects against diabetes-associated behavioral deficits in rats: Possible involved mechanisms
Yaghoob Farbood et al.
LIFE SCIENCES (2019)
Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet
Chian-Jiun Liou et al.
CELLS (2019)
Hepatic Steatosis Index Is Associated with Type I Diabetes Complications
Cesare Tripolino et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Ellagic acid attenuates streptozocin induced diabetic nephropathy via the regulation of oxidative stress and inflammatory signaling
Benhong Zhou et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
Dongwei Xu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway
Cong Zhang et al.
FOOD & FUNCTION (2019)
Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes
Laura Sviklane et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Naringin attenuates liver damage in streptozotocin-induced diabetic rats
Valeria Rodriguez et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
Ana Ruth Araujo et al.
LIVER INTERNATIONAL (2018)
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Mario Masarone et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats
Simran Alexandria Polce et al.
NUTRIENTS (2018)
Improving the Reliability and Utility of Streptozotocin-Induced Rat Diabetic Model
Yanlin Wang-Fischer et al.
JOURNAL OF DIABETES RESEARCH (2018)
Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas
Noor Fatima et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPAR-Dependent AMPK Activation
Camila O. de Souza et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone
Rakesh P. Nankar et al.
PHYTOMEDICINE (2017)
Persicarin isolated from Oenanthe javanica protects against diabetes-induced oxidative stress and inflammation in the liver of streptozotocin-induced type 1 diabetic mice
Joo Young Lee et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Hironori Kitade et al.
NUTRIENTS (2017)
Protective effects of ellagic acid in D-galactosamine-induced kidney damage in rats
Adnan Ayhanci et al.
CYTOTECHNOLOGY (2016)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Pterostilbene Ameliorates Streptozotocin-Induced Diabetes through Enhancing Antioxidant Signaling Pathways Mediated by Nrf2
Bhakkiyalakshmi Elango et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and diabetes
Jonathan M. Hazlehurst et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes
Inhae Kang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid, and Quercetin from Radix Sanguisorbae
Chang-Seob Seo et al.
PHARMACOGNOSY MAGAZINE (2016)
Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy
Amin Hasanvand et al.
INFLAMMOPHARMACOLOGY (2016)
Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling
Hong Tang et al.
EBIOMEDICINE (2016)
Activated AMPK boosts the Nrf2/HO-1 signaling axis-A role for the unfolded protein response
Kristin Zimmermann et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms
Meshail Okla et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection
Wylly Ramses Garcia-Nino et al.
PHARMACOLOGICAL RESEARCH (2015)
Curcumin protects rat liver from streptozotocin-induced diabetic pathophysiology by counteracting reactive oxygen species and inhibiting the activation of p53 and MAPKs mediated stress response pathways
Shatadal Ghosh et al.
TOXICOLOGY REPORTS (2015)
The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice
Chunfen Mo et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Simultaneous analysis and peroxynitrite-scavenging activity of galloylated flavonoid glycosides and ellagic acid in Euphorbia supina
Agung Nugroho et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy
Amjid Ahad et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Ellagic acid protects Lipbpolysaccharide/D-galactosamine-induced acute hepatic injury in mice
Lei Gu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Protective effect of ellagic acid against TCDD-induced renal oxidative stress: Modulation of CYP1A1 activity and antioxidant defense mechanisms
Viswanadha Vijaya Padma et al.
MOLECULAR BIOLOGY REPORTS (2014)
Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction
Sumanta Kumar Goswami et al.
PHARMACOGNOSY MAGAZINE (2014)
Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-Ay mice
Yukihiro Yoshimura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway
Hai Yan Quan et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease
Brice Sid et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Antioxidant Action of Ellagic Acid Ameliorates Paraquat-Induced A549 Cytotoxicity
Yong-Sik Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
AMPK, insulin resistance, and the metabolic syndrome
Neil B. Ruderman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease
Tung-Ming Leung et al.
JOURNAL OF HEPATOLOGY (2013)
A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats
Christopher R. Lindholm et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats
M. Mari Kannan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Effect of Caloric Restriction and AMPK Activation on Hepatic Nuclear Receptor, Biotransformation Enzyme, and Transporter Expression in Lean and Obese Mice
Supriya R. Kulkarni et al.
PHARMACEUTICAL RESEARCH (2013)
The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis
Fatma Ucar et al.
REDOX REPORT (2013)
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat
Gurbet Celik et al.
BIOMED RESEARCH INTERNATIONAL (2013)
AMP-activated protein kinase, stress responses and cardiovascular diseases
Shaobin Wang et al.
CLINICAL SCIENCE (2012)
Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes
You-Cheng Hseu et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass
Birgit Knebel et al.
PLOS ONE (2012)
Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease
M. A. Rosillo et al.
BIOCHEMICAL PHARMACOLOGY (2011)
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Ellagic Acid Stimulates Glucose Transport in Adipocytes and Muscles through AMPK Mediated Pathway
Ninu Poulose et al.
JOURNAL OF DIABETES & METABOLISM (2011)
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
S. Fogarty et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Protective effects of Pycnogenol® on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats
Kehkashan Parveen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats
P. Palsamy et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Xanthine oxidase-induced oxidative stress causes activation of NF-κB and inflammation in the liver of type I diabetic rats
Marco Romagnali et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect
Daniel E. Frances et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
B. Viollet et al.
ACTA PHYSIOLOGICA (2009)
Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
A. Peairs et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Ellagic Acid Inhibits Pancreatic Fibrosis in Male Wistar Bonn/Kobori Rats
Noriaki Suzuki et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
AMP-Activated Protein Kinase Suppresses LXR-Dependent Sterol Regulatory Element-Binding Protein-1c Transcription in Rat Hepatoma McA-RH7777 Cells
Jian Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Gyoergy Baffy
JOURNAL OF HEPATOLOGY (2009)
Effect of ellagic acid, a plant polyphenol, on fibrotic markers (MMPs and TIMPs) during alcohol-induced hepatotoxicity
N. Devipriya et al.
TOXICOLOGY MECHANISMS AND METHODS (2007)
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
Anatol Panasiuk et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Mechanisms of liver injury. III. Role of glutathione redox status in liver injury
Derick Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats
K Tomita et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia
S Enoksson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Regulation of rat glutamate-cysteine ligase (γ-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B1-induced preneoplasia
AG Shepherd et al.
CARCINOGENESIS (2000)
Share Paper
